stocksAAKAAR
AAKAAR

Aakaar Medical Technologies Ltd.

60.50-3.2 (-4.95%)
7 Aug, 12:00 AM

Income Statement

Abridged
Understanding Income Statement
Aakaar Medical Technologies Ltd. income statement covering revenue, operating profit, EBITDA, PAT and EPS across annual and quarterly periods.
2022
Mar 31
2023
Mar 31
2024
Mar 31
2025
Mar 31
2026
Mar 31
Period length:
Source:
12M
PR
12M
PR
12M
PR
12M
PR
12M
AR
Total Revenue
19.4732.7846.1161.5866.96
Cost of Operating Revenue
9.0915.1021.0726.3528.33
Gross Profit
10.3817.6925.0435.2338.63
Gross Margin
53.354.054.357.257.7
Total Operating Expenses
17.0929.3541.2551.9756.78
Operating Profit
2.373.444.869.6110.18
Operating Margin
12.210.510.515.615.2
Financing Income/(Expense) - Net
-0.20-0.42-1.12-1.70-1.02
Profit before Taxes
2.203.103.898.089.19
Income Taxes
0.590.951.022.042.55
Profit after Tax
1.622.152.876.046.64
PAT Margin
8.36.66.29.89.9
EPS - Basic - ex Extraordinary Items
1.141.522.034.264.99
EPS - Diluted - ex Extraordinary Items
1.141.522.034.264.99
EBIT
2.373.444.869.6110.18
EBITDA
2.403.535.009.7410.31
EBITDA Margin
12.310.810.815.815.4

Balance Sheet

Abridged
Understanding Balance Sheet
Aakaar Medical Technologies Ltd. balance sheet covering assets, liabilities, equity and borrowings across annual and quarterly periods.
2022
Mar 31
2023
Mar 31
2024
Mar 31
2025
Mar 31
2026
Mar 31
Source:
PR
PR
PR
PR
AR
Total Current Assets
17.3322.2232.8151.8576.61
Property Plant & Equipment - Net
0.200.360.270.230.17
Total Non-Current Assets
0.671.011.202.252.80
Total Assets
18.0023.2334.0154.1079.42
Total Current Liabilities
9.4512.9120.6429.9623.88
Total Non-Current Liabilities
0.520.660.830.950.98
Total Liabilities
9.9713.5721.4730.9024.87
Total Shareholders' Equity
8.039.6612.5423.2054.55
Total Equity
8.039.6612.5423.2054.55
Total Liabilities & Equity
18.0023.2334.0154.1079.42

Cash Flow

Abridged
Understanding Cash Flow Statement
Aakaar Medical Technologies Ltd. cash flow statement covering operating, investing and financing activities across annual and quarterly periods.
2022
Mar 31
2023
Mar 31
2024
Mar 31
2025
Mar 31
2026
Mar 31
Period length:
Source:
12M
PR
12M
PR
12M
PR
12M
PR
12M
AR
Operating CF bef Changes in Working Cap
1.752.903.717.687.16
Working Capital - Increase/(Decrease)
-1.25-5.82-11.73-13.08-16.60
Net CF from Operating Activities
0.50-2.92-8.02-5.40-9.44
Capital Expenditures - Net
0.190.260.050.080.58
Net CF from Investing Activities
-0.24-0.32-0.06-0.06-0.53
Stock - Issuance/(Retirement) - Net
---5.2627.00
Debt - LT & ST - Issuance/(Retirement) - Total
-0.072.069.187.68-4.20
Net Cash Flow from Financing Activities
-0.811.178.1910.7120.45
Free Cash Flow to Equity
0.25-1.131.112.20-14.22
Free Operating CF net dividend
0.31-3.19-8.07-5.49-10.02
Free Operating CF
0.31-3.19-8.07-5.49-10.02

Business Segment Analysis

Aakaar Medical Technologies Ltd. business segment breakdown covering revenue, operating income and assets across key divisions for the selected financial year.

We don't have enough data to show business segment analysis for Aakaar Medical Technologies Ltd.

Regional Segment Analysis

Aakaar Medical Technologies Ltd. geographic revenue split showing domestic and international market performance across revenue and income for the selected financial year.

We don't have enough data to show regional segment analysis for Aakaar Medical Technologies Ltd.

Historical Segment Analysis

Track how Aakaar Medical Technologies Ltd. segment contributions have evolved over multiple financial years to see which divisions are growing, shrinking or gaining strategic importance.

We don't have enough data to show segments for Aakaar Medical Technologies Ltd.

Frequently Asked Questions

What is the revenue of Aakaar Medical Technologies Ltd.?
The latest trailing twelve month revenue of Aakaar Medical Technologies Ltd. is ₹ 66.96 Cr, reflecting a 1-year growth of 8.74% and a 3-year CAGR of 26.88%. Annual and quarterly revenue trends are available in the Income Statement section.
What is the net profit of Aakaar Medical Technologies Ltd.?
The latest trailing twelve month net profit (PAT) of Aakaar Medical Technologies Ltd. is ₹ 6.64 Cr, with a 3-year earnings CAGR of 48.65%. Detailed profit history across annual and quarterly periods is in the Income Statement section.
What is the EBITDA of Aakaar Medical Technologies Ltd.?
The trailing twelve month EBITDA of Aakaar Medical Technologies Ltd. is approximately ₹ 10.18 Cr (based on an operating margin of 15.21%). EBITDA reflects core operating profitability before interest, taxes, depreciation and amortisation.
What is the EPS of Aakaar Medical Technologies Ltd.?
The trailing twelve month Earnings Per Share (EPS) of Aakaar Medical Technologies Ltd. is 4.99. EPS trends across annual and quarterly periods are visible in the Income Statement section.
What is the debt level of Aakaar Medical Technologies Ltd.?
The debt-to-equity ratio of Aakaar Medical Technologies Ltd. stands at 0.34. The interest coverage ratio is 6.16x, reflecting the company's ability to service debt from operating earnings. The full breakdown of total borrowings is in the Balance Sheet section.
What is the book value per share of Aakaar Medical Technologies Ltd.?
The estimated book value per share of Aakaar Medical Technologies Ltd. is 38.49 (derived from a P/B ratio of 1.57 and market price of ₹ 60.50), reflecting the net asset value attributable to each share. See the Balance Sheet section for a full breakdown.
What is the cash flow from operations of Aakaar Medical Technologies Ltd.?
The trailing twelve month operating cash flow of Aakaar Medical Technologies Ltd. is ₹ -9.44 Cr. Annual and quarterly cash flow data is available in the Cash Flow section of the Statements tab.
Does Aakaar Medical Technologies Ltd. report consolidated or standalone financials?
Aakaar Medical Technologies Ltd. reports consolidated financials. You can toggle between consolidated and standalone views using the switch at the top of each statement section.